As of Nov 19, 2026, 2 of 2 active firms rate VANI a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
VANI EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.07 – $-0.07 · 1 analysts · -12% YoY
Next period, 1 analysts expect Vivani Medical Inc. to earn $-0.07 a share (range $-0.07 – $-0.07), versus $-0.08 a year earlier. Full-year consensus is $-0.32, growing to $-0.39 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Vivani Medical Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on VANI.
#1
Jaeson Schmidt
Lake Street · Rank #64
Buy
$4.00+284.6% to target
Overall win rate
43%
+ Follow
#2
TF
Thomas Flaten
Lake Street · Rank #306
Buy
$4.00+284.6% to target
Overall win rate
40%
+ Follow
#3
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$3.50+236.5% to target
Overall win rate
34%
+ Follow
VANI stock forecast FAQ
What is VANI's average 12-month price target?+
The 2 active firms with a live target average $3.75 for Vivani Medical Inc. over the next 12 months, ranging from a $4.00 high to a $3.50 low, as of Nov 19, 2026.
Is VANI stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for VANI?+
The Street-high target is $4.00 (Lake Street), and the Street-low is $3.50 (HC Wainwright & Co.). The average of all 2 active-firm targets is $3.75.
How many active Wall Street firms cover VANI?+
2 active firms have a recognized rating on Vivani Medical Inc. as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering VANI?+
Among analysts who currently cover VANI, Jaeson Schmidt of Lake Street has the strongest overall Quantellect track record (Rank #64). Their current call is Buy with a $4.00 target.
What is Vivani Medical Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.07 – $-0.07) across 1 analysts. Full-year EPS is projected at $-0.32, rising to $-0.39 the following year.
How much revenue is Vivani Medical Inc. expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading VANI lately?+
As of Nov 19, 2026, 2 of 2 active firms rate VANI a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their VANI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.